INPhINIT 2019 "la Caixa" fellowship programme

The doctoral fellowship programme INPhINIT "la Caixa" is devoted to attracting talented Early-Stage Researchers-of any nationality-who wish to pursue doctoral studies in Spanish or Portuguese territory. Sponsored by "la Caixa" Foundation, it is aimed at supporting the best scientific talent and fostering innovative and high-quality research in Spain and Portugal by recruiting outstanding international students and offering them an attractive and competitive environment for conducting research of excellence.

The doctoral INPhINIT fellowships offer a highly competitive salary and complementary opportunities for training on transferrable skills (through the collaboration of leading entities such as Vitae and Oxentia), temporary stays in industry, incentives upon completion of the thesis, among other elements that make these fellowships some of the most attractive and complete in Europe.

INPhINIT collaborates with the top research centres in Spain, which will host INPhINIT fellows in one of their PhD programmes. More information about the programme here.

Check out below the PhD open positions at the IGTP:

  • Dynamic 3D Chromatin Organization in Human Hematopoiesis: study of the contributions of non-coding genetic variants and mutations in pediatric acute lymphoblastic leukaemia with the aim of identifying novel disease-associated genes ' Biola Javierre
  • Regulation of epigenetic plasticity and 3D chromatin architecture through histone variants ' Marcus Buschbeck
  • 3D chromatin architecture in acute myeloid leukaemia ' Marcus Buschbeck
  • Combined adipose flap and myocardial scaffolds enriched by multifunctional extracellular vesicles for cardiac tissue engineering: Pre-Clinical and Clinical Studies ' Antoni Bayés
  • GeoInf+ (PI18/01512) / GeoINF + project. Genetic study of the impact of gEographic environmental exposure on INFlamatory markers in the adult population / PhD student ' Rafael De Cid
  • Tuberculosis diagnosis. Characterization of homing T-cell markers for the diagnosis of tuberculosis ' Jose Antonio Domínguez Benítez
  • Tolerance induction for multiple sclerosis and other autoimmune diseases: new pathways and therapeutic targets ' Eva M Martínez Cáceres
  • Synonymous virus genome recoding as a tool to impact HIV fitness ' Miguel Ángel Martínez
  • The Genomic Architecture of Cancer. Genetic and epigenetic determinants of reprogramming in cancer, functional and clinical insights ' Miquel Àngel Peinado
  • Novel cytokines involved in the development of type 2 diabetes during obesity ' David Sánches-Infantes
  • Precision medicine for childhood liver cancer. Moving forward a precision medicine for childhood liver cancer: prospective prognostic biomarker validation and establishment of innovative models for therapy assessment ' Carol Armengol
  • Development of an humanized new model of ischemic stroke in pig by endovascular access (minimally invasive and transient): dynamic study of cerebral infarction and reperfusion using multimodal image ' Antoni Dávalos
  • Exploring the molecular underpinnings of TNBL, a novel IncRNA from a macrosatellite repeat overexpressed in colon cancer ' Sonia Forcales
  • Deciphering the molecular basis of metastatic thyroid cancer: study of DNA methylome and transcriptome. Development of translational tools ' Mireia Jordà
  • AAV-mediated gene therapy for the treatment of Friedreich Ataxia ' Antoni Matilla
  • Pancreatic beta cell identity ' Lorenzo Pasquali
  • Phenotypic and functional study of macrophages in liver cancer: towards the development of new therapeutic opportunities ' Maria Rosa Sarrias
  • Translational studies in myelodysplastic syndromes ' Francesc Solé